Sho Matsui

539 total citations
8 papers, 370 citations indexed

About

Sho Matsui is a scholar working on Molecular Biology, Surgery and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Sho Matsui has authored 8 papers receiving a total of 370 indexed citations (citations by other indexed papers that have themselves been cited), including 3 papers in Molecular Biology, 2 papers in Surgery and 2 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Sho Matsui's work include Kruppel-like factors research (2 papers), Glycosylation and Glycoproteins Research (1 paper) and Fibroblast Growth Factor Research (1 paper). Sho Matsui is often cited by papers focused on Kruppel-like factors research (2 papers), Glycosylation and Glycoproteins Research (1 paper) and Fibroblast Growth Factor Research (1 paper). Sho Matsui collaborates with scholars based in Japan. Sho Matsui's co-authors include Takashi Iwazawa, Akira Nagafuchi, Takatoshi Kadowaki, Shunsuke Tamura, Keisuke Iihara, Hironori Shiozaki, Hideki Oka, Y. Doki, Gideon Goldstein and Ben K. Seon and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Diabetologia and Autophagy.

In The Last Decade

Sho Matsui

7 papers receiving 355 citations

Peers

Sho Matsui
Comparison fields: 5 of 52
  • Molecular Biology 284
  • Oncology 68
  • Surgery 53
  • Cell Biology 39
  • Pulmonary and Respiratory Medicine 30
Replace Toshio HARADA with:
Toshio HARADA Japan
Ken-ichirou Morishige Japan
Martijn Gerretsen Netherlands
Sarah Petrie United States
Emmanuelle Astoul United Kingdom
Taihei Kageyama Japan
Tess A. Stanly United Kingdom
Tomoko Fujikane Japan
Tomáš Frgala United States
Toshio HARADA Japan View profile →
Citations per field, relative to Sho Matsui
Sho Matsui · 1×
Citations per year, relative to Sho Matsui
Sho Matsui · 1×

Countries citing papers authored by Sho Matsui

Since Specialization
Citations

This map shows the geographic impact of Sho Matsui's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sho Matsui with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sho Matsui more than expected).

Fields of papers citing papers by Sho Matsui

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Sho Matsui. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sho Matsui. The network helps show where Sho Matsui may publish in the future.

Co-authorship network of co-authors of Sho Matsui

This figure shows the co-authorship network connecting the top 25 collaborators of Sho Matsui. A scholar is included among the top collaborators of Sho Matsui based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Sho Matsui. Sho Matsui is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

8 of 8 papers shown
# Work Indexed citations
1 0
2 7
3 15
4 11
5 5
6
E-cadherin and alpha-catenin expression in human esophageal cancer.
232
7 75
8 25

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026